• TRIAL ALERTS

• HEALTH NEWS

• RSS FEEDS

• ABOUT TRIALS

• LINK TO US

Results from Clinical Connection:

(Hide Results...)

Your search returned 4 studies. (Get alerts for new studies): Irritable Bowel Syndrome (with diarrhea) - Pittsburgh PA Irritable Bowel Syndrome (with diarrhea) - Pittsburgh P A Irritable Bowel Syndrome (with diarrhea) - Pittsburgh PA Irritable Bowel Syndrome (with diarrhea) - Belle Vernon PA

Results from other databases:

(Hide Results...)

Your search returned 12 studies: Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study Conditions: Irritable Bowel Syndrome With Diarrhea Location: Pittsburgh, Pennsylvania Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J Conditions: Irritable Bowel Syndrome Location: Belle Vernon, Pennsylvania Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J Conditions: Irritable Bowel Syndrome Location: Pittsburgh, Pennsylvania Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J Conditions: Irritable Bowel Syndrome Location: Pittsburgh, Pennsylvania Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J Conditions: Irritable Bowel Syndrome Location: Upper St. Clair, Pennsylvania Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J Conditions: Irritable Bowel Syndrome Location: Carnegie, Pennsylvania Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J Conditions: Irritable Bowel Syndrome Location: Pittsburgh, Pennsylvania Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J Conditions: Irritable Bowel Syndrome Location: Pittsburgh, Pennsylvania Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J Conditions: Irritable Bowel Syndrome Location: Scottdale, Pennsylvania Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (Protocol J Conditions: Irritable Bowel Syndrome Location: Uniontown, Pennsylvania Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD) Conditions: Clostridium Difficile-associated Diarrhea Location: Pittsburgh, Pennsylvania Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Conditions: Clostridium Difficile-Associated Diarrhea (CDAD) Location: Pittsburgh, Pennsylvania

Didn't find what you were looking for? Try these alternatives: